Alison Norton
Chelsea and Westminster Hospital · 14 works · 563 citations · h-index 9
Top works
- Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin
- Recurrent responses to non-small cell lung cancer brain metastases with erlotinib
- Discordance between cancer prevalence and training: a need for an increase in oncology education
- An Association of Cancer Physicians’ strategy for improving services and outcomes for cancer patients
- Low-Dose Oral Fluorouracil With Eniluracil as First-Line Chemotherapy Against Advanced Breast Cancer: A Phase II Study
- The association of chemotherapy induced neutropenia on treatment outcomes in small cell lung cancer
- Early Response to Platinum-Based First-Line Chemotherapy in Non-small Cell Lung Cancer May Predict Survival
- Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer
- A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice
- Fadrozole and letrozole in advanced breast cancer: Clinical and biochemical effects
- Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?
- P-356 Addition of SRL172 (Mycobacterium vaccae) to standard chemotherapy in small cell lung cancer (SCLC) confers no survival benefit: Results of a randomised multicentre study
- Randomised Evaluation of STents to Open REstricted AIRways in patients with centrally placed non-small cell lung cancer
- O-251 Weight loss and anaemia are poor prognostic factors for patients with lung cancer receiving chemotherapy — will modification of these prognostic factors become a new standard of care?